Fusion Protein Technologies for Biopharmaceuticals: Applications and Challenges

Fusion Protein Technologies for Biopharmaceuticals: Applications and Challenges

for $ 156.99

156.99 Fusion Protein Technologies for Biopharmaceuticals: Applications and Challenges http://covers.feedbooks.net/item/432114.jpg?t=1397100033 http://www.feedbooks.com/item/432114/fusion-protein-technologies-for-biopharmaceuticals-applications-and-challenges?utm_medium=uwishlist&utm_source=amazon

The state of the art in biopharmaceutical FUSION PROTEIN DESIGN

Fusion proteins belong to the most lucrative biotech drugs—with Enbrel® being one of the best-selling biologics worldwide. Enbrel® represents a milestone of modern therapies just as Humulin®, the first therapeutic recombinant protein for human use, approved by the FDA in 1982 and Orthoclone® the first monoclonal antibody reaching the market in 1986. These first generation molecules were soon followed… (more)

Comments (0 comments)


No comment yet. Sign in to post a comment.

Book Details  


Publisher: Wiley (January 28, 2013)

Format: EPUB

Page count: 664 pages

File size: 11.4 MB

Protection: DRM

Language: English


Look for similar items  


>
>